514 related articles for article (PubMed ID: 18032957)
1. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
2. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
3. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
4. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
5. Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant.
Kuskonmaz B; Güçer S; Boztepe G; Cetin M; Uckan D
Pediatr Transplant; 2007 Mar; 11(2):214-6. PubMed ID: 17300504
[TBL] [Abstract][Full Text] [Related]
6. Progressive autologous graft-versus-host disease induced by cyclosporin A.
Barredo JC; Yusuf U; Hahn A; Abboud MR; Laver J
Bone Marrow Transplant; 1996 Sep; 18(3):659-62. PubMed ID: 8879637
[TBL] [Abstract][Full Text] [Related]
7. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
Kikuta A; Suzuki H
Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
[TBL] [Abstract][Full Text] [Related]
9. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
[No Abstract] [Full Text] [Related]
11. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
[TBL] [Abstract][Full Text] [Related]
12. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Gerber M; Gmeinhart B; Volc-Platzer B; Kalhs P; Greinix H; Knobler R
Bone Marrow Transplant; 1997 Mar; 19(5):517-9. PubMed ID: 9052923
[TBL] [Abstract][Full Text] [Related]
13. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
16. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
17. Tretinoin for the treatment of cutaneous graft-versus-host disease.
Gryn J; Crilley P
Bone Marrow Transplant; 1990 Apr; 5(4):279-80. PubMed ID: 2104506
[TBL] [Abstract][Full Text] [Related]
18. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features in patients with hepatic graft-versus-host disease.
Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
